JPH10120546A - Skin whitening preparation for external use - Google Patents

Skin whitening preparation for external use

Info

Publication number
JPH10120546A
JPH10120546A JP8297384A JP29738496A JPH10120546A JP H10120546 A JPH10120546 A JP H10120546A JP 8297384 A JP8297384 A JP 8297384A JP 29738496 A JP29738496 A JP 29738496A JP H10120546 A JPH10120546 A JP H10120546A
Authority
JP
Japan
Prior art keywords
fraction
whitening
skin
fractionation
zucc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP8297384A
Other languages
Japanese (ja)
Inventor
Megumi Obayashi
恵 大林
Yuri Okano
由利 岡野
Hitoshi Masaki
仁 正木
Atsuko Imahori
篤子 今堀
Masumi Takei
増美 竹井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP8297384A priority Critical patent/JPH10120546A/en
Publication of JPH10120546A publication Critical patent/JPH10120546A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject preparation high in melanogenesis inhibitory effect, stability and safety, and free from unfavorable color and odor. SOLUTION: This skin whitening preparation is obtained by formulating a base preparation for external use with suitably 0.0001-5.0wt.% or so of a (-)-epicatechin-contg. fraction which is afforded by the following process: a polar solvent extract from at least one kind of plant selected from Polygonum cuspidatum Sieb. et Zucc., Polygonum cuspidatum Sieb. et Zucc. var. hachidyoense Ohwi and Polygonum sachalinense Fr. Schm. is concentrated under reduced pressures, the resultant concentrate is dissolved in 30vol.% ethanol again and then subjected to fractionation by resin column chromatography followed by elution with 40vol.% ethanol, and the resultant fraction is further fractionated by silica gel chromatography.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は特定の植物抽出物よ
り分画,精製して得られた画分を含有して成る、メラニ
ン生成抑制効果に優れる美白用皮膚外用剤に関する。さ
らに詳しくは、イタドリ(Polygonum cuspidatum Sieb.
et Zucc.),ハチジョウイタドリ(Polygonum cuspida
tum Sieb. et Zucc. var. hachidyoense Ohwi),及び
オオイタドリ(Polygonum sachalinense Fr. Schm.)か
ら選ばれる1種又は2種以上の植物の極性溶媒による抽
出物をさらに分画,精製して得た画分を含有して成る美
白用皮膚外用剤に関する。
TECHNICAL FIELD The present invention relates to an external preparation for skin whitening having an excellent effect of inhibiting melanin production, comprising a fraction obtained by fractionation and purification from a specific plant extract. For more information, see the Japanese knotweed ( Polygonum cuspidatum Sieb.
et Zucc.), Honey beebird ( Polygonum cuspida)
tum Sieb. et Zucc. var. hachidyoense Ohwi), and Ooitadori (Polygonum sachalinense Fr. Schm. Further fractionation of the extract by a polar solvent of one or more plants selected from) image obtained by purification The present invention relates to an external preparation for skin whitening comprising

【0002】[0002]

【従来の技術】従来より、皮膚のシミ,ソバカスといっ
た色素沈着症状を改善する上で、美白用皮膚外用剤は非
常に関心の深いものであり、これらにおいてはアスコル
ビン酸,システイン,グルタチオン,コロイドイオウ等
が有効成分として用いられていた。また、種々の薬用植
物抽出物や、植物由来の没食子酸,カルコン,カテキン
類等のフラボノイド、コウジ酸、ハイドロキノン配糖体
などが美白剤として知られている。
2. Description of the Related Art In the past, skin external preparations for whitening have been of great interest in improving pigmentation symptoms such as skin spots and freckles. Among these, ascorbic acid, cysteine, glutathione, and colloid sulfur And the like have been used as active ingredients. Also, various medicinal plant extracts, flavonoids such as gallic acid, chalcone, and catechins derived from plants, kojic acid, hydroquinone glycosides, and the like are known as whitening agents.

【0003】しかしながら、アスコルビン酸は酸化され
やすく不安定であり、システイン,グルタチオン,コロ
イドイオウは特有の異臭や沈殿が生じるといった欠点を
有していた。また、薬用植物の抽出物については、メラ
ニン生成抑制効果が不十分であったり、使用に際し好ま
しくない色や臭いを有していたり、一定した品質のもの
が得られにくいといった問題があった。また、コウジ酸
等についても、製剤中での安定性の維持に配慮が必要で
あり、さらに連用により副作用の生じるおそれのあるも
のも存在していた。
[0003] However, ascorbic acid is easily oxidized and unstable, and cysteine, glutathione and colloidal sulfur have disadvantages such as generation of peculiar off-odor and precipitation. In addition, the medicinal plant extract has problems that the melanin production inhibitory effect is insufficient, that the extract has an undesired color or odor upon use, and that it is difficult to obtain a product of constant quality. Also, regarding kojic acid and the like, it is necessary to consider the maintenance of stability in the preparation, and there is also a substance that may cause side effects due to continuous use.

【0004】[0004]

【発明が解決しようとする課題】本発明者らは、上記し
たような課題を解決する手段として、イタドリ(Polygo
num cuspidatum Sieb. et Zucc.),ハチジョウイタド
リ(Polygonum cuspidatum Sieb. et Zucc. var. hach
idyoense Ohwi),及びオオイタドリ(Polygonumsachal
inense Fr. Schm.)から選ばれる1種又は2種以上の植
物の抽出物を含有する美白化粧料及びチロシナーゼ生合
成阻害剤についてすでに開示している(特開平5−29
4819,特開平8−104646)。本発明において
は、さらにメラニンの生成抑制効果が高く、常に安定し
た品質を有し、色や臭い等の問題もない美白用皮膚外用
剤を提供することを目的とした。
As a means for solving the above-mentioned problems, the inventors of the present invention have proposed a knotweed ( Polygo).
num . cuspidatum Sieb. et Zucc.), Honey beebird ( Polygonum cuspidatum Sieb. et Zucc. var. hach)
idyoense Ohwi) and Giant Knotweed ( Polygonumsachal )
Inense Fr. Schm.) has already disclosed a whitening cosmetic and a tyrosinase biosynthesis inhibitor containing one or more plant extracts selected from JP-A-5-29.
4819, JP-A-8-104646). In the present invention, an object of the present invention is to provide an external preparation for whitening skin which has a high melanin production inhibitory effect, has always stable quality, and has no problems such as color and odor.

【0005】[0005]

【課題を解決するための手段】上記の課題を解決するた
め、イタドリ等の抽出物の分画,精製を試みたところ、
今回高いメラニン生成抑制効果を有する画分の分取に成
功し、それを外用剤基剤に含有させることにより、色素
沈着症状の改善効果が高く、安定で且つ安全性も高い美
白用皮膚外用剤を得ることができた。
In order to solve the above problems, fractionation and purification of extracts such as knotweed were attempted.
This time, we succeeded in fractionation of a fraction that has a high melanin production inhibitory effect, and by incorporating it into an external preparation base, it has a high effect of improving pigmentation symptoms and is stable and highly safe. Could be obtained.

【0006】すなわち本発明においては、イタドリ(Po
lygonum cuspidatum Sieb. et Zucc.),ハチジョウイ
タドリ(Polygonum cuspidatum Sieb. et Zucc. var.
hachidyoense Ohwi),及びオオイタドリ(Polygonum s
achalinense Fr. Schm.)から選ばれる1種又は2種以
上の植物の極性溶媒による抽出物を減圧濃縮し、30容
量%エタノールに再溶解して樹脂カラムクロマトグラフ
ィーによる分画を行い、40容量%エタノールで溶出さ
れる画分をさらにシリカゲルクロマトグラフィーにより
分画して得られる画分のうち、(-)-エピカテキンを豊富
に含む画分を、皮膚外用剤基剤に含有させて成る。
That is, in the present invention, the knotweed ( Po
lypidum cuspidatum Sieb. et Zucc.) and the bee housebird ( Polygonum cuspidatum Sieb. et Zucc. var.)
hachidyoense Ohwi) and Giant Knotweed ( Polygonum s)
achalinense Fr. Schm.), an extract of one or more plants selected from polar solvents is concentrated under reduced pressure, redissolved in 30% by volume of ethanol, fractionated by resin column chromatography, and subjected to 40% by volume. Among the fractions obtained by further fractionating the fraction eluted with ethanol by silica gel chromatography, a fraction rich in (-)-epicatechin is contained in a skin external preparation base.

【0007】[0007]

【作用】本発明に係る美白用皮膚外用剤は、従来の美白
用皮膚外用剤に比べて優れたメラニン生成抑制作用を示
し、且つ常に一定の安定したメラニン生成抑制作用が期
待でき、さらに製剤安定性及び安全性が良好である。ま
た、好ましくない着色や異臭も見られない。
The skin whitening preparation for external use according to the present invention exhibits a superior melanin production inhibitory action as compared with the conventional skin whitening preparation, and can always expect a constant and stable melanin generation inhibitory action. Good in safety and safety. Also, no undesired coloring or unpleasant odor is observed.

【0008】[0008]

【発明の実施の形態】本発明において、分画,精製の出
発原料とする抽出物は、イタドリ等の花,葉,茎,根及
び全草を用いて得ることができるが、特に根より抽出し
たものが好ましい。抽出溶媒としては、メタノール,エ
タノール,プロパノール,イソプロパノール,ブタノー
ル,エチレングリコール,ジエチレングリコール,プロ
ピレングリコール,ジプロピレングリコール,1,3-ブチ
レングリコール,グリセリン,酢酸メチル,酢酸エチ
ル,酢酸イソプロピル,エチルエーテル,イソプロピル
エーテル,アセトン等の極性の高い有機溶媒の1種又は
2種以上、或いはこれらと水との混合物を用いるのが、
メラニン生成抑制作用の点で好ましい。抽出は、植物を
生のまま、又は乾燥して細切又は粉砕し、室温から抽出
溶媒の沸点以下の温度にて、2時間〜2週間程度浸漬し
て行う。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, an extract as a starting material for fractionation and purification can be obtained using flowers, leaves, stems, roots, and whole plants of knotweeds, and particularly extracted from roots. Are preferred. Examples of the extraction solvent include methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, methyl acetate, ethyl acetate, isopropyl acetate, ethyl ether, and isopropyl ether. The use of one or more organic solvents having a high polarity, such as acetone, acetone, or a mixture of these with water
It is preferable from the viewpoint of melanin production inhibitory action. The extraction is performed by cutting or pulverizing the plant as it is or by drying it, and immersing it at a temperature from room temperature to the boiling point of the extraction solvent or lower for about 2 hours to 2 weeks.

【0009】イタドリ等の抽出物は必要に応じてろ過
し、次いで減圧濃縮した後、30容量%のエタノールに
再溶解し、沈殿,浮遊物が生じた場合はろ過する。これ
を樹脂カラムクロマトグラフィーにより分画する。樹脂
カラムとしては、DIAIONMCI Gel HP−
20(三菱化成株式会社製)が好ましく使用できる。前
記樹脂カラムクロマトグラフィーにおいて、40容量%
エタノールにより溶出される画分を集め、さらにシリカ
ゲル薄層クロマトグラフィーにより分画する。その際の
展開溶媒としては、クロロホルム,メタノールの容量比
5:1の混合物が好ましい。
[0009] The extract such as knotweed is filtered as necessary, and then concentrated under reduced pressure, and then redissolved in 30% by volume of ethanol. This is fractionated by resin column chromatography. DIAION MCI Gel HP-
20 (manufactured by Mitsubishi Kasei Corporation) can be preferably used. In the resin column chromatography, 40% by volume
The fraction eluted with ethanol is collected and further fractionated by silica gel thin layer chromatography. As a developing solvent at that time, a mixture of chloroform and methanol at a volume ratio of 5: 1 is preferable.

【0010】上記シリカゲル薄層クロマトグラフィーに
おいて得られる画分のうち、CD3OD NMRにより
(-)-エピカテキンと同定される物質を含有する画分に強
いメラニン抑制作用が認められるため、この画分を回収
し、抽出に用いる高極性の有機溶媒若しくはそれらと水
との混合物に溶解させ、皮膚外用剤基剤に添加する。皮
膚外用剤中における前記画分の配合量としては、0.0
001〜5.0重量%程度が適当である。
[0010] Of the fractions obtained in the above silica gel thin layer chromatography, CD 3 OD NMR
The fraction containing the substance identified as (-)-epicatechin has a strong melanin-suppressing action.This fraction is collected and dissolved in a highly polar organic solvent used for extraction or a mixture of these and water. And add to the skin external preparation base. The amount of the fraction in the skin external preparation was 0.0
About 001 to 5.0% by weight is appropriate.

【0011】なお本発明においては、イタドリ等の分
画,精製画分に加えて他の美白剤を添加することができ
る。また、本発明の特徴を損なわない範囲で、油類,保
湿剤,紫外線吸収剤,香料,抗酸化剤,防腐剤等、一般
的な外用剤及び化粧料用原料をも含有させることができ
る。
In the present invention, other whitening agents can be added in addition to the fractionation and purification fractions of knotweed and the like. In addition, general external preparations such as oils, humectants, ultraviolet absorbers, fragrances, antioxidants, preservatives, and raw materials for cosmetics can be contained within a range that does not impair the features of the present invention.

【0012】本発明は、ローション剤,乳剤,ゲル剤,
クリーム,軟膏等の剤型の美白用皮膚外用剤として提供
することができる。また、化粧水,乳液,クリーム等の
皮膚用化粧料、メイクアップベースローション,メイク
アップベースクリーム,液状又はクリーム状或いは軟膏
型のファンデーション等のメイクアップ化粧料、日焼け
止めローション,日焼け止めクリーム等の日焼け止め化
粧料、ハンドクリーム,レッグクリーム,ボディローシ
ョン等の身体用化粧料などとしても提供され得る。
The present invention relates to a lotion, an emulsion, a gel,
It can be provided as an external preparation for skin whitening in the form of creams, ointments and the like. Also, skin cosmetics such as lotions, emulsions and creams, makeup base lotions, makeup base creams, makeup cosmetics such as liquid or creamy or ointment type foundations, sunscreen lotions, sunscreen creams, etc. It can also be provided as sunscreen cosmetics, body cosmetics such as hand cream, leg cream, body lotion and the like.

【0013】[0013]

【実施例】さらに本発明について、実施例により詳細に
説明する。まず、本発明に係る美白用皮膚外用剤に含有
させるイタドリ等の分画,精製画分の調製例を以下に示
す。
EXAMPLES The present invention will be described in more detail with reference to Examples. First, preparation examples of fractionation and purification fractions of knotweed and the like to be contained in the skin whitening external preparation of the present invention are shown below.

【0014】イタドリ(Polygonum cuspidatum Sieb. e
t Zucc.)の乾燥粉末200gを、50容量%エタノー
ル水溶液2lに浸漬し、室温にて1週間抽出を行った。
抽出液をろ過後減圧濃縮し、30容量%エタノール水溶
液にて800mlとしてさらにろ過し、ろ液をDIAI
ON MCI Gel HP−20(三菱化成株式会社
製)カラムにて分画した。40容量%エタノール水溶液
にて溶出される画分を集め、これをさらにシリカゲル薄
層クロマトグラフィーにて、クロロホルム,メタノール
混合物(容量比=5:1)を展開溶媒として用いて分画
した。得られた画分のうち、(-)-エピカテキンを含む画
分を掻き取り、50容量%エタノール水溶液に溶解させ
てイタドリ分画,精製画分とした。
Itami ( Polygonum cuspidatum Sieb. E)
t Zucc.) was immersed in 2 l of a 50% by volume aqueous ethanol solution and extracted at room temperature for one week.
The extract was filtered, concentrated under reduced pressure, made 800 ml with a 30% by volume aqueous ethanol solution, and further filtered.
Fractionation was performed using an ON MCI Gel HP-20 (manufactured by Mitsubishi Kasei Corporation) column. The fraction eluted with a 40% by volume aqueous ethanol solution was collected, and further fractionated by silica gel thin layer chromatography using a mixture of chloroform and methanol (volume ratio = 5: 1) as a developing solvent. Among the obtained fractions, the fraction containing (-)-epicatechin was scraped off and dissolved in a 50% by volume aqueous ethanol solution to give a knotweed fraction and a purified fraction.

【0015】上記のイタドリ分画,精製画分のメラニン
生成抑制作用について、次に示す。メラニン生成抑制作
用は、B16メラノーマ細胞を用いて評価した。まず、B
16メラノーマ細胞を培養ディッシュ(直径60mm)当
たり1.5×105個となるように播種し、50mM乳
酸ナトリウムを含む10容量%牛胎仔血清含有DMEM
培地5ml中で37℃にて4日間前培養を行った。次い
で試料として種々の最終濃度のイタドリ分画,精製画分
を含有する5容量%牛胎仔血清含有DMEM培地5ml
に培地交換を行い、37℃にて3日間の本培養を行っ
た。この際、対照及びネガティブ対照として、5容量%
牛胎仔血清含有DMEM培地のみ及び40mM乳酸ナト
リウムを含む5容量%牛胎仔血清含有DMEM培地にて
それぞれ培養を行った。本培養終了後、B16メラノーマ
細胞を分離し、650nm及び400nmにおける吸光
度を測定し、同時に細胞数の測定を行った。各濃度にお
けるイタドリ分画,精製画分のメラニン生成抑制阻害率
は(1)式により求めた。
The action of inhibiting the production of melanin in the above-mentioned knotweed fraction and purified fraction is described below. The melanin production inhibitory effect was evaluated using B16 melanoma cells. First, B
16 melanoma cells were seeded at 1.5 × 10 5 cells per culture dish (diameter 60 mm), and DMEM containing 10 mM fetal calf serum containing 50 mM sodium lactate was used.
Preculture was performed at 37 ° C. for 4 days in 5 ml of medium. Then, as a sample, 5 ml of a 5% by volume fetal bovine serum-containing DMEM medium containing a variety of final concentration of knotweed and purified fractions
The medium was exchanged, and main culture was performed at 37 ° C. for 3 days. At this time, 5% by volume as a control and a negative control
The culture was performed using only the DMEM medium containing fetal calf serum and the DMEM medium containing 5% by volume fetal calf serum containing 40 mM sodium lactate. After completion of the main culture, B16 melanoma cells were separated, the absorbance at 650 nm and 400 nm was measured, and the number of cells was measured at the same time. The inhibition rate of melanin production inhibition of the knotweed fraction and the purified fraction at each concentration was determined by equation (1).

【数1】 (式中、A650C,A400C,NCはそれぞれ対照における
650nm,400nmにおける吸光度及び細胞数、A
650S,A400S,NSはそれぞれ試料を添加した際の65
0nm,400nmにおける吸光度及び細胞数を示
す。)
(Equation 1) ( Where A 650C , A 400C , and N C are the absorbance and cell number at 650 nm and 400 nm in the control, respectively.
650S, A 400S, 65 when N S is that each addition of sample
The absorbance at 0 nm and 400 nm and the number of cells are shown. )

【0016】イタドリ分画,精製画分の各濃度における
メラニン生成抑制効果を表1に示した。表1において、
イタドリ分画,精製画分は0.6μg/ml程度で約1
0%のメラニン生成抑制を示し、40μg/mlの添加
ではメラニン生成抑制率は20%を越えていた。なお、
ネガティブ対照においては、ほぼ完全にメラニン生成が
抑制されていたが、(-)-エピカテキン単独では、最終濃
度が40μg/mlとなるように添加した場合、有意な
メラニン生成抑制は見られなかった。従って、イタドリ
分画,精製画分においては、(-)-エピカテキン以外の含
有成分がメラニン生成抑制作用の主体となっているか、
或いは(-)-エピカテキンと他の含有成分との相互作用に
よりメラニン生成が抑制されている可能性が考えられ
た。
Table 1 shows the melanin production inhibitory effect at each concentration of the knotweed fraction and the purified fraction. In Table 1,
Itadori fraction and purified fraction are about 0.6 μg / ml and about 1
It showed 0% inhibition of melanin production, and the melanin production inhibition rate exceeded 20% with the addition of 40 μg / ml. In addition,
In the negative control, melanin production was almost completely inhibited, but with (-)-epicatechin alone, no significant inhibition of melanin production was observed when added to a final concentration of 40 μg / ml. . Therefore, in the knotweed fraction and the purified fraction, whether the components other than (-)-epicatechin are the main components of the melanin production inhibitory action,
Alternatively, it was considered that melanin production was suppressed by the interaction between (-)-epicatechin and other components.

【表1】 [Table 1]

【0017】続いて、本発明の実施例に係る美白用皮膚
外用剤の処方を示す。なお、イタドリ等の分画,精製画
分としては、上記に調製例として示したものを用いた。
Subsequently, the formulation of the skin whitening agent for external use according to the embodiment of the present invention will be described. As the fractions and purified fractions of Itadori and the like, those described above as Preparation Examples were used.

【0018】 [実施例1] 美白ローション (1)エタノール 10.0(重量%) (2)ヒドロキシエチルセルロース 1.0 (3)イタドリ分画,精製画分 0.1 (4)精製水 88.9 製法:(1)〜(3)を順次(4)に添加し、均一に混合,溶解
する。
Example 1 Whitening lotion (1) Ethanol 10.0 (wt%) (2) Hydroxyethylcellulose 1.0 (3) Itadori fractionation, purified fraction 0.1 (4) Purified water 88.9 Production method: (1) to (3) are sequentially added to (4) and uniformly mixed and dissolved.

【0019】 [実施例2] 美白用乳剤 (1)ステアリン酸 0.2(重量%) (2)セタノール 1.5 (3)ワセリン 3.0 (4)流動パラフィン 7.0 (5)ポリオキシエチレン(10E.O.)モノオレエート 1.5 (6)酢酸トコフェロール 5.0 (7)グリセリン 5.0 (8)パラオキシ安息香酸メチル 0.1 (9)トリエタノールアミン 1.0 (10)精製水 75.4 (11)イタドリ分画,精製画分 0.3 製法:(1)〜(6)の油相成分を混合,加熱して均一に溶解
し、70℃に保つ。一方、(7)〜(10)の水相を混合,加
熱して均一とし、70℃とする。この水相成分に前記油
相成分を攪拌しながら徐々に添加して乳化し、冷却した
後40℃にて(11)を添加,混合する。
Example 2 Whitening Emulsion (1) Stearic acid 0.2 (% by weight) (2) Cetanol 1.5 (3) Vaseline 3.0 (4) Liquid paraffin 7.0 (5) Polyoxy Ethylene (10E.O.) monooleate 1.5 (6) Tocopherol acetate 5.0 (7) Glycerin 5.0 (8) Methyl parahydroxybenzoate 0.1 (9) Triethanolamine 1.0 (10) Purified water 75.4 (11) Itadori fractionation, purified fraction 0.3 Production method: The oil phase components (1) to (6) are mixed, heated and uniformly dissolved, and kept at 70 ° C. On the other hand, the aqueous phases (7) to (10) are mixed and heated to be uniform, and the temperature is set to 70 ° C. The oil phase component is gradually added to the aqueous phase component while stirring to emulsify, and after cooling, (11) is added and mixed at 40 ° C.

【0020】 [実施例3] 美白用ゲル剤 (1)ジプロピレングリコール 10.0(重量%) (2)カルボキシビニルポリマー 0.5 (3)水酸化カリウム 0.1 (4)パラオキシ安息香酸メチル 0.1 (5)精製水 88.1 (6)アスコルビン酸リン酸エステルマグネシウム塩 1.0 (7)イタドリ分画,精製画分 0.2 製法:(5)に(2)を均一に溶解させた後、(1)に(4)を溶解
させて添加し、次いで(3)を加えて増粘させ、(6),(7)
を添加,混合する。
Example 3 Whitening Gel (1) Dipropylene glycol 10.0 (% by weight) (2) Carboxyvinyl polymer 0.5 (3) Potassium hydroxide 0.1 (4) Methyl paraoxybenzoate 0.1 (5) Purified water 88.1 (6) Magnesium ascorbic acid phosphate ester 1.0 (7) Itadori fractionation, purified fraction 0.2 Production method: (2) is uniformly dissolved in (5) After that, (4) was dissolved and added to (1), then (3) was added to increase the viscosity, and (6), (7)
Add and mix.

【0021】 [実施例4] 皮膚用クリーム (1)ミツロウ 6.0(重量%) (2)セタノール 5.0 (3)還元ラノリン 8.0 (4)スクワラン 27.5 (5)グリセリル脂肪酸エステル 4.0 (6)親油型グリセリルモノステアレート 2.0 (7)ポリオキシエチレン(20E.O.)ソルビタン 5.0 モノラウレート (8)プロピレングリコール 5.0 (9)パラオキシ安息香酸メチル 0.1 (10)精製水 36.9 (11)イタドリ分画,精製画分 0.5 製法:(1)〜(7)の油相成分を混合,溶解して75℃に加
熱する。一方、(8)〜(10)の水相成分を混合,溶解して
75℃に加熱する。次いで、上記水相成分に油相成分を
添加して予備乳化した後、ホモミキサーにて均一に乳化
し、冷却後40℃にて(11)を添加,混合する。
Example 4 Skin Cream (1) Beeswax 6.0 (% by weight) (2) Cetanol 5.0 (3) Reduced Lanolin 8.0 (4) Squalane 27.5 (5) Glyceryl fatty acid ester 4.0 (6) Lipophilic glyceryl monostearate 2.0 (7) Polyoxyethylene (20E.O.) sorbitan 5.0 Monolaurate (8) Propylene glycol 5.0 (9) Methyl paraoxybenzoate 0.1 (10) Purified water 36.9 (11) Itadori fractionation, purified fraction 0.5 Production method: Mix and dissolve the oil phase components of (1) to (7) and heat to 75 ° C. On the other hand, the aqueous phase components (8) to (10) are mixed and dissolved, and heated to 75 ° C. Next, the oil phase component is added to the water phase component and pre-emulsified, and then uniformly emulsified by a homomixer. After cooling, (11) is added and mixed at 40 ° C.

【0022】 [実施例5] 水中油型乳剤性美白軟膏 (1)白色ワセリン 25.0(重量%) (2)ステアリルアルコール 25.0 (3)グリセリン 12.0 (4)ラウリル硫酸ナトリウム 1.0 (5)パラオキシ安息香酸メチル 0.1 (6)精製水 35.9 (7)イタドリ分画,精製画分 1.0 製法:(1)〜(4)の油相成分を混合,溶解して均一とし、
75℃に加熱する。一方、(5)及び(6)の水相成分を混
合,溶解して75℃に加熱し、これに前記油相成分を添
加して乳化し、冷却後40℃にて(7)を添加,混合す
る。
Example 5 Oil-in-water emulsion whitening ointment (1) White petrolatum 25.0 (% by weight) (2) Stearyl alcohol 25.0 (3) Glycerin 12.0 (4) Sodium lauryl sulfate 1. 0 (5) Methyl paraoxybenzoate 0.1 (6) Purified water 35.9 (7) Itadori fractionation, purified fraction 1.0 Production method: Mix and dissolve the oil phase components (1) to (4) And uniform
Heat to 75 ° C. On the other hand, the aqueous phase components (5) and (6) were mixed and dissolved, heated to 75 ° C, and the oil phase component was added thereto to emulsify. After cooling, (7) was added at 40 ° C. Mix.

【0023】 [実施例6] 美白化粧水 (1)エタノール 10.00(重量%) (2)1,3-ブチレングリコール 5.00 (3)イタドリ分画,精製画分 0.01 (4)香料 0.10 (5)精製水 84.89 製法:(1)〜(4)を順次(5)に添加し、均一に混合,溶解
する。
Example 6 Whitening Lotion (1) Ethanol 10.00 (% by weight) (2) 1,3-butylene glycol 5.00 (3) Itadori fractionation, purified fraction 0.01 (4) Fragrance 0.10 (5) Purified water 84.89 Production method: (1) to (4) are sequentially added to (5), and uniformly mixed and dissolved.

【0024】 [実施例7] 美白用油中水型クリーム (1)流動パラフィン 30.00(重量%) (2)マイクロクリスタリンワックス 2.00 (3)ワセリン 5.00 (4)ジグリセリルジオレエート 5.00 (5)L-グルタミン酸ナトリウム 1.60 (6)L-セリン 0.40 (7)プロピレングリコール 3.00 (8)パラオキシ安息香酸メチル 0.10 (9)精製水 52.78 (10)イタドリ分画,精製画分 0.02 (11)香料 0.10 製法:(5),(6)を(9)の一部に溶解して50℃とし、5
0℃に加熱した(4)に攪拌しながら徐々に添加する。こ
れをあらかじめ混合し70℃に加熱溶解した(1)〜(3)に
均一に分散し、これに(7),(8)を(9)の残部に溶解して
70℃に加熱溶解したものを攪拌しながら添加し、ホモ
ミキサーにて乳化する。冷却後、40℃にて(10),(11)
を添加する。
[Example 7] Water-in-oil cream for whitening (1) Liquid paraffin 30.00 (wt%) (2) Microcrystalline wax 2.00 (3) Vaseline 5.00 (4) Diglyceryldiole Ethate 5.00 (5) Sodium L-glutamate 1.60 (6) L-Serine 0.40 (7) Propylene glycol 3.00 (8) Methyl parahydroxybenzoate 0.10 (9) Purified water 52.78 ( 10) Itadori fractionation, purified fraction 0.02 (11) Fragrance 0.10 Production method: (5) and (6) are dissolved in a part of (9) to 50 ° C and 5 ° C.
Add slowly to (4) heated to 0 ° C. with stirring. This was previously mixed and uniformly dispersed in (1) to (3), which were heated and dissolved at 70 ° C., and (7) and (8) were dissolved in the remainder of (9) and heated and dissolved at 70 ° C. Is added with stirring and emulsified with a homomixer. After cooling, at 40 ° C (10), (11)
Is added.

【0025】 [実施例8] 美白用メイクアップベースクリーム (1)ステアリン酸 12.00(重量%) (2)セタノール 2.00 (3)グリセリルトリ2-エチルヘキサノエート 2.50 (4)自己乳化型グリセリルモノステアレート 2.00 (5)プロピレングリコール 10.00 (6)水酸化カリウム 0.30 (7)パラオキシ安息香酸メチル 0.10 (8)精製水 69.45 (9)二酸化チタン 1.00 (10)ベンガラ 0.10 (11)黄酸化鉄 0.40 (12)香料 0.10 (13)イタドリ分画,精製画分 0.05 製法:(1)〜(4)の油相成分を混合し、75℃に加熱して
均一とする。一方(5)〜(8)の水相成分を混合し、75℃
に加熱,溶解して均一とし、これに(9)〜(11)の顔料を
添加し、ホモミキサーにて均一に分散させる。この水相
成分に前記油相成分を添加し、ホモミキサーにて乳化し
た後冷却し、40℃にて(12),(13)を添加,混合する。
Example 8 Whitening Makeup Base Cream (1) Stearic acid 12.00 (% by weight) (2) Cetanol 2.00 (3) Glyceryl tri-2-ethylhexanoate 2.50 (4) Self-emulsifying glyceryl monostearate 2.00 (5) Propylene glycol 10.00 (6) Potassium hydroxide 0.30 (7) Methyl parahydroxybenzoate 0.10 (8) Purified water 69.45 (9) Titanium dioxide 1.00 (10) Bengala 0.10 (11) Yellow iron oxide 0.40 (12) Fragrance 0.10 (13) Itadori fractionation, purified fraction 0.05 Production method: oils of (1) to (4) The phase components are mixed and heated to 75 ° C. to make uniform. On the other hand, mix the aqueous phase components (5) to (8)
The mixture is heated and dissolved to make the mixture uniform, and the pigments (9) to (11) are added to the mixture and uniformly dispersed by a homomixer. The oil phase component is added to the water phase component, emulsified by a homomixer, cooled, and (12) and (13) are added and mixed at 40 ° C.

【0026】 [実施例9] 美白用液状ファンデーション (1)ステアリン酸 2.00(重量%) (2)スクワラン 5.00 (3)ミリスチン酸オクチルドデシル 5.00 (4)セタノール 1.00 (5)ポリグリセリルモノイソパルミテート 9.00 (6)1,3-ブチレングリコール 6.00 (7)水酸化カリウム 0.10 (8)パラオキシ安息香酸メチル 0.10 (9)精製水 53.66 (10)酸化チタン 9.00 (11)ベンガラ 7.40 (12)黄酸化鉄 0.50 (13)黒酸化鉄 1.10 (14)香料 0.10 (15)イタドリ分画,精製画分 0.04 製法:(1)〜(5)の油相成分を混合し、75℃に加熱して
均一とする。一方(6)〜(9)の水相成分を混合し、75℃
に加熱,溶解して均一とし、これに(10)〜(13)の顔料を
添加し、ホモミキサーにて均一に分散させる。この水相
成分に前記油相成分を添加し、ホモミキサーにて乳化し
た後冷却し、40℃にて(14),(15)を添加,混合する。
[Example 9] Liquid foundation for whitening (1) Stearic acid 2.00 (wt%) (2) Squalane 5.00 (3) Octyldodecyl myristate 5.00 (4) Cetanol 1.00 (5 ) Polyglyceryl monoisopalmitate 9.00 (6) 1,3-butylene glycol 6.00 (7) Potassium hydroxide 0.10 (8) Methyl parahydroxybenzoate 0.10 (9) Purified water 53.66 (10 ) Titanium oxide 9.00 (11) Bengala 7.40 (12) Yellow iron oxide 0.50 (13) Black iron oxide 1.10 (14) Fragrance 0.10 (15) Itadori fractionation and purification fraction 04 Production method: The oil phase components (1) to (5) are mixed and heated to 75 ° C. to make it uniform. On the other hand, the aqueous phase components of (6) to (9) were mixed and
The mixture is heated and dissolved to make the mixture uniform, and the pigments (10) to (13) are added to the mixture and uniformly dispersed by a homomixer. The oil phase component is added to the aqueous phase component, emulsified with a homomixer, cooled, and (14) and (15) are added and mixed at 40 ° C.

【0027】 [実施例10] 日焼け止め用乳液 (1)オレイルオレエート 5.0(重量%) (2)ジメチルポリシロキサン 3.0 (3)ワセリン 0.5 (4)セタノール 1.0 (5)ソルビタンセスキオレエート 0.8 (6)ポリオキシエチレン(20E.O.)オレイルアルコール 1.2 エーテル (7)パラメトキシ桂皮酸2-エチルヘキシル 2.0 (8)オキシベンゾン 3.0 (9)ジプロピレングリコール 6.0 (10)ヒドロキシエチルセルロース 0.3 (11)パラオキシ安息香酸メチル 0.1 (12)精製水 73.9 (13)エタノール 3.0 (14)香料 0.1 (15)イタドリ分画,精製画分 0.1 製法:(1)〜(8)の油相成分を混合,溶解して70℃とす
る。一方、(9)〜(12)の水相成分を混合,溶解して70
℃とし、これに前記油相成分を攪拌しながら徐々に添加
して乳化する。冷却後、40℃にて(13)〜(15)を添加,
混合する。
Example 10 Sunscreen Emulsion (1) Oleyl Oleate 5.0 (% by weight) (2) Dimethylpolysiloxane 3.0 (3) Vaseline 0.5 (4) Cetanol 1.0 (5 ) Sorbitan sesquioleate 0.8 (6) Polyoxyethylene (20E.O.) oleyl alcohol 1.2 ether (7) 2-Ethylhexyl paramethoxycinnamate 2.0 (8) Oxybenzone 3.0 (9) Dipropylene Glycol 6.0 (10) Hydroxyethylcellulose 0.3 (11) Methyl paraoxybenzoate 0.1 (12) Purified water 73.9 (13) Ethanol 3.0 (14) Fragrance 0.1 (15) Itadori fraction Purified fraction 0.1 Production method: Mix and dissolve oil phase components (1) to (8) to 70 ° C. On the other hand, the aqueous phase components (9) to (12)
° C, and the oil phase component is gradually added to this while stirring to emulsify. After cooling, add (13)-(15) at 40 ° C,
Mix.

【0028】 [実施例11] 美白用ハンドクリーム (1)ステアリン酸 3.00(重量%) (2)グリセリルモノステアレート 3.00 (3)セタノール 2.00 (4)流動パラフィン 6.00 (5)ワセリン 3.00 (6)グリセリン 10.00 (7)1,3-ブチレングリコール 5.00 (8)水酸化カリウム 0.25 (9)パラオキシ安息香酸メチル 0.10 (10)精製水 67.32 (11)アスコルビン酸リン酸エステルマグネシウム塩 0.25 (12)イタドリ分画,精製画分 0.08 製法:(1)〜(5)の油相成分を混合,溶解して75℃とす
る。一方、(6)〜(10)の水相成分を混合,溶解して75
℃とし、これに前記油相成分を攪拌しながら徐々に添加
して乳化する。冷却後、40℃にて(11),(12)を添加,
混合する。
Example 11 Whitening Hand Cream (1) Stearic acid 3.00 (% by weight) (2) Glyceryl monostearate 3.00 (3) Cetanol 2.00 (4) Liquid paraffin 6.00 ( 5) Vaseline 3.00 (6) Glycerin 10.00 (7) 1,3-butylene glycol 5.00 (8) Potassium hydroxide 0.25 (9) Methyl parahydroxybenzoate 0.10 (10) Purified water 67 32 (11) Magnesium salt of ascorbic acid phosphate ester 0.25 (12) Itadori fractionation, purified fraction 0.08 Production method: Mix and dissolve the oil phase components (1) to (5) to 75 ° C. I do. On the other hand, the aqueous phase components (6) to (10)
° C, and the oil phase component is gradually added to this while stirring to emulsify. After cooling, add (11) and (12) at 40 ° C,
Mix.

【0029】上記本発明の実施例のうち、実施例1〜実
施例5について色素沈着症状の改善効果を評価した。そ
の際、各実施例において、イタドリの分画,精製画分を
50容量%エタノール水溶液に代替したものをそれぞれ
比較例1〜比較例5とした。色素沈着症状の改善効果
は、顕著なシミ,ソバカス等の色素沈着症状を有する女
性パネラー20名を1群とし、各群に実施例及び比較例
をそれぞれブラインドにて1日2回ずつ1カ月間使用さ
せ、1カ月後の皮膚の色素沈着の状態を観察して使用前
と比較して評価した。色素沈着の状態は表2に示す判定
基準に従って評価し、20名の平均値を算出して表3に
示した。
Of the above Examples of the present invention, Examples 1 to 5 were evaluated for the effect of improving pigmentation symptoms. At that time, in each of the examples, the fractionation and purification fractions of the knotweed were replaced with 50% by volume aqueous ethanol solution, and these were designated as Comparative Examples 1 to 5, respectively. The effect of improving the pigmentation symptom was as follows: 20 female panelists with remarkable pigmentation symptoms such as spots and freckles were grouped as one group, and the examples and comparative examples were blinded twice a day for each group for one month. After one month, the state of pigmentation of the skin after one month was observed and compared with that before use. The state of pigmentation was evaluated in accordance with the criteria shown in Table 2, and the average value of 20 persons was calculated and shown in Table 3.

【表2】 [Table 2]

【0030】[0030]

【表3】 表3において明らかなように、本発明の実施例使用群で
は明確な色素沈着症状の改善が認められていた。特に、
イタドリの分画,精製画分とアスコルビン酸リン酸エス
テルマグネシウム塩を併用した実施例3については、相
乗的な美白効果の向上が認められ、またイタドリの分
画,精製画分含量の高い実施例4及び実施例5使用群に
ついても、ほとんどのパネラーにおいて、色素沈着は微
少な程度にまで改善されていた。これに対し、比較例3
以外の比較例使用群では、いずれも明確な改善は認めら
れておらず、比較例3使用群でも色素沈着症状の改善の
程度は小さかった。
[Table 3] As is clear from Table 3, in the group using the examples of the present invention, a clear improvement in pigmentation symptoms was observed. Especially,
In Example 3, in which the fractionation and purification of Knotweed was combined with magnesium ascorbate phosphate, a synergistic improvement in whitening effect was observed, and in Example 3 where the fractionation and purification of Knotweed were high. Regarding the groups using Example 4 and Example 5, pigmentation was improved to a slight extent in almost all panelists. In contrast, Comparative Example 3
No clear improvement was observed in any of the groups using Comparative Examples other than the above, and the degree of improvement in the pigmentation symptoms was small in the group using Comparative Example 3 as well.

【0031】続いて、本発明の実施例10及び実施例1
1を用いて色素沈着の防止効果を評価した。各実施例に
おいて、イタドリの分画,精製画分を50容量%エタノ
ール水溶液で代替したものを比較例10及び比較例11
とし、実施例とともに戸外で作業することの多いパネラ
ーによる使用試験を行った。パネラーとしては、日常戸
外で作業する20才〜50才代の男女を選択し、1群2
0名とした。各群のパネラーにそれぞれブラインドにて
実施例及び比較例を1日2回使用させ、1カ月後の皮膚
の色素沈着状態を上記表2に示す判定基準に従って評価
し、試験開始前と比較した。なお、使用試験は紫外線量
の多い5月に行った。結果は20名の平均値にて表4に
示した。
Subsequently, Embodiment 10 and Embodiment 1 of the present invention
1 was used to evaluate the effect of preventing pigmentation. Comparative Examples 10 and 11 were obtained by substituting the fractionated and purified fractions of Knotweed with a 50% by volume aqueous ethanol solution in each Example.
A usage test was conducted by panelists who often work outdoors together with the examples. As panelists, men and women in their 20s and 50s who work outdoors every day were selected,
0 people. Examples and comparative examples were used twice a day by blinds of panelists in each group, and the state of pigmentation of the skin after one month was evaluated according to the criteria shown in Table 2 above, and compared with that before the test was started. The use test was conducted in May when the amount of ultraviolet rays was large. The results are shown in Table 4 by the average value of 20 persons.

【0032】[0032]

【表4】 表4において、比較例使用群についても若干の皮膚の色
素沈着の防止効果は認められるが、本発明の実施例使用
群では、戸外作業中被曝する紫外線により生じる色素沈
着が顕著に抑制されているばかりか、色素沈着症状の改
善も認められていた。
[Table 4] In Table 4, although some effects of preventing skin pigmentation were observed in the group using the comparative example, in the group using the example of the present invention, pigmentation caused by ultraviolet rays exposed during outdoor work was significantly suppressed. In addition, improvement in pigmentation symptoms was also observed.

【0033】また、本発明の実施例については、調製時
に顕著な着色や異臭を生じることはなく、室温にて1年
以上保存した後にも、外観変化及び色素沈着症状の防
止,改善効果の低下は認められなかった。さらに、皮膚
に対し刺激性,感作性,光感作性等の悪影響も認められ
なかった。
In Examples of the present invention, no remarkable coloring or off-flavor is produced at the time of preparation, and even after storage at room temperature for 1 year or more, the appearance change and the prevention of pigmentation symptoms and the reduction of the improvement effect are reduced. Was not found. Further, no adverse effects such as irritation, sensitization and photosensitization on the skin were observed.

【0034】[0034]

【発明の効果】以上詳述したように、本発明によりメラ
ニンの生成抑制効果が高く、有効な皮膚色素沈着の改善
及び防止効果を有し、常に安定した品質を有し、色や臭
い等の問題もない美白用皮膚外用剤を提供することがで
きた。
As described above in detail, the present invention has a high melanin production inhibitory effect, has an effective effect of improving and preventing skin pigmentation, has always stable quality, and has a stable color and odor. It was possible to provide a skin whitening agent for external use without any problem.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 正木 仁 滋賀県八日市市岡田町字野上112−1 株 式会社ノエビア滋賀中央研究所内 (72)発明者 今堀 篤子 滋賀県八日市市岡田町字野上112−1 株 式会社ノエビア滋賀中央研究所内 (72)発明者 竹井 増美 滋賀県八日市市岡田町字野上112−1 株 式会社ノエビア滋賀中央研究所内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hitoshi Masaki 112-1 Nogami, Okada-cho, Yokaichi, Shiga Prefecture Inside the Noevir Shiga Central Research Laboratory Co., Ltd. (72) Inventor Atsuko Imabori 112-Nogami, Okada-cho, Yokaichi, Shiga 1 Noevir Shiga Central Research Institute, Inc. (72) Inventor Masumi Takei 112-1 Nogami, Okada-cho, Yokaichi-shi, Shiga Pref.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 イタドリ(Polygonum cuspidatum Sieb.
et Zucc.),ハチジョウイタドリ(Polygonum cuspida
tum Sieb. et Zucc. var. hachidyoense Ohwi),及び
オオイタドリ(Polygonum sachalinense Fr. Schm.)か
ら選ばれる1種又は2種以上の植物の極性溶媒による抽
出物を減圧濃縮し、30容量%エタノールに再溶解して
樹脂カラムクロマトグラフィーによる分画を行い、40
容量%エタノールで溶出される画分をさらにシリカゲル
クロマトグラフィーにより分画して得られる、(-)-エピ
カテキンを含む画分を含有することを特徴とする、美白
用皮膚外用剤。
1. A knotweed ( Polygonum cuspidatum Sieb.
et Zucc.), Honey beebird ( Polygonum cuspida)
tum Sieb. et Zucc. var. hachidyoense Ohwi), and Ooitadori (Polygonum sachalinense Fr. Schm. One or extract with a polar solvent of two or more plants selected from) and concentrated under reduced pressure, re to 30 volume% ethanol After dissolution and fractionation by resin column chromatography, 40
An external preparation for whitening skin, comprising a fraction containing (-)-epicatechin, which is obtained by further fractionating a fraction eluted with a volume% of ethanol by silica gel chromatography.
【請求項2】 請求項1に記載された画分の含有量が、
0.0001〜5.0重量%であることを特徴とする、
美白用皮膚外用剤。
2. The content of the fraction according to claim 1,
0.0001 to 5.0% by weight,
An external preparation for skin whitening.
【請求項3】 美白用皮膚外用剤が、美白化粧料である
ことを特徴とする、請求項1又は請求項2に記載の皮膚
外用剤。
3. The skin external preparation according to claim 1, wherein the whitening skin external preparation is a whitening cosmetic.
JP8297384A 1996-10-18 1996-10-18 Skin whitening preparation for external use Withdrawn JPH10120546A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8297384A JPH10120546A (en) 1996-10-18 1996-10-18 Skin whitening preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8297384A JPH10120546A (en) 1996-10-18 1996-10-18 Skin whitening preparation for external use

Publications (1)

Publication Number Publication Date
JPH10120546A true JPH10120546A (en) 1998-05-12

Family

ID=17845800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8297384A Withdrawn JPH10120546A (en) 1996-10-18 1996-10-18 Skin whitening preparation for external use

Country Status (1)

Country Link
JP (1) JPH10120546A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11349435A (en) * 1998-06-03 1999-12-21 Noevir Co Ltd Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light
KR20020080656A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for antioxidation
KR20020080655A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for skin whitening
JP2004043514A (en) * 2003-11-14 2004-02-12 Noevir Co Ltd Endothelin-1 inhibitor
JP2006124355A (en) * 2004-11-01 2006-05-18 Ichimaru Pharcos Co Ltd Phagocytosis inhibitor
JP2007182420A (en) * 2005-12-30 2007-07-19 Ind Technol Res Inst Medicinal herb composition having free radical suppressing action and health food containing the medicinal herb composition
US8980336B2 (en) 2005-12-30 2015-03-17 Industrial Technology Research Institute Method for inhibiting free radicals

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11349435A (en) * 1998-06-03 1999-12-21 Noevir Co Ltd Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light
KR20020080656A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for antioxidation
KR20020080655A (en) * 2001-04-17 2002-10-26 주식회사 참 존 Cosmetics comprising Polygonum extracts for skin whitening
JP2004043514A (en) * 2003-11-14 2004-02-12 Noevir Co Ltd Endothelin-1 inhibitor
JP2006124355A (en) * 2004-11-01 2006-05-18 Ichimaru Pharcos Co Ltd Phagocytosis inhibitor
JP2007182420A (en) * 2005-12-30 2007-07-19 Ind Technol Res Inst Medicinal herb composition having free radical suppressing action and health food containing the medicinal herb composition
US8980336B2 (en) 2005-12-30 2015-03-17 Industrial Technology Research Institute Method for inhibiting free radicals

Similar Documents

Publication Publication Date Title
WO1997019044A1 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
JP3839618B2 (en) Elastase inhibitor, and anti-aging skin external preparation comprising the same
JP2003300860A (en) Skin care preparation
JP2002370922A (en) Cosmetic containing japanese plum extract
JPH10330219A (en) Melanogenesis inhibitor and skin whitening agent
JP2000143479A (en) Skin-bleaching cosmetic
JP2000319155A (en) Matrix metalloprotease inhibitor, and aging preventive lotion containing the same
JPH07187988A (en) Melanism inhibitor, its production and skin-beautifying containing the same cosmetic
JPH1180002A (en) Preparation for external use for skin preventing aging
JPH10120546A (en) Skin whitening preparation for external use
JP2001163757A (en) Preparation for external use for skin
JP2001114636A (en) Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JP2002114685A (en) Melanogenesis inhibitor and bleaching agent comprising ergosterol derivative and composition containing ergosterol derivative
JP2896815B2 (en) Cosmetics
JPH07252128A (en) Skin external preparation
JPH1036246A (en) Suppressant for melanogenesis and preparation for external use for skin
JP2004307437A (en) Skin care preparation for external use for preventing aging
JP2000256175A (en) Cosmetic composition
JPH11335225A (en) Skin lotion
JPH11302149A (en) Melanin production inhibitor and external preparation for skin containing the same
JPH01149706A (en) Skin-beautifying cosmetic
JP2002068956A (en) Skin cosmetic
JPH09157151A (en) Melanin generation inhibitor and whitening agent
JPH1149695A (en) Skin lotion for preventing aging
JP4402278B2 (en) Whitening cosmetics

Legal Events

Date Code Title Description
A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20040407